-
1دورية أكاديمية
المؤلفون: Motzer, Robert J, Taylor, Matthew H, Evans, Thomas R Jeffry, Okusaka, Takuji, Glen, Hilary, Lubiniecki, Gregory M, Dutcus, Corina, Smith, Alan D, Okpara, Chinyere E, Hussein, Ziad, Hayato, Seiichi, Tamai, Toshiyuki, Makker, Vicky
المصدر: Articles, Abstracts, and Reports
مصطلحات موضوعية: oregon, portland, chiles, Antineoplastic Agents, Carcinoma, Renal Cell, Humans, Iodine Radioisotopes, Kidney Neoplasms, Liver Neoplasms, Phenylurea Compounds, Protein Kinase Inhibitors, Quinolines, Thyroid Neoplasms, Oncology, Pharmacy and Pharmaceutical Sciences
العلاقة: https://digitalcommons.psjhealth.org/publications/5902Test; https://pubmed.ncbi.nlm.nih.gov/35260027Test
-
2
المؤلفون: Lee, Chung-Han, Shah, Amishi Yogesh, Rasco, Drew, Rao, Arpit, Taylor, Matthew H., Di Simone, Christopher, Hsieh, James J., Pinto, Alvaro, Shaffer, David R., Sarrio, Regina Girones, Cohn, Allen Lee, Vogelzang, Nicholas J., Bilen, Mehmet Asim, Ribe, Sara Gunnestad, Goksel, Musaberk, Tennøe, Øyvind Krohn, Richards, Donald, Sweis, Randy F., Courtright, Jay, Heinrich, Daniel, Jain, Sharad, Wu, Jane, Schmidt, Emmett V., Perini, Rodolfo F., Kubiak, Peter, Okpara, Chinyere E., Smith, Alan D., Motzer, Robert J.
المصدر: Lancet Oncol
مصطلحات موضوعية: Male, Time Factors, Phenylurea Compounds, Middle Aged, Antibodies, Monoclonal, Humanized, Article, Kidney Neoplasms, United States, Europe, Antineoplastic Agents, Immunological, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols, Quinolines, Humans, Female, Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Protein Kinase Inhibitors, Aged
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::152d44b7915dbc60e2b4f6f2110b4f47Test
https://europepmc.org/articles/PMC8316679Test/ -
3دورية أكاديمية
المؤلفون: Gaspar, Nathalie, Campbell-Hewson, Quentin, Huang, Jie, Okpara, Chinyere E, Bautista, Francisco
المصدر: Future Oncology; Oct2021, Vol. 17 Issue 32, p4249-4261, 13p
مصطلحات موضوعية: THERAPEUTIC use of antineoplastic agents, ETOPOSIDE, QUINOLINE, RESEARCH, UREA, CLINICAL trials, PROTEIN kinase inhibitors, OSTEOSARCOMA, RESEARCH methodology, IFOSFAMIDE, EVALUATION research, BONE tumors, COMPARATIVE studies, RANDOMIZED controlled trials, QUALITY of life
-
4دورية أكاديمية
المؤلفون: González-Martín, Antonio1 (AUTHOR) agonzalezma@unav.es, Chung, Hyun Cheol2 (AUTHOR) UNCHUNG8@yuhs.ac, Saada-Bouzid, Esma3 (AUTHOR) Esma.SAADA-BOUZID@nice.unicancer.fr, Yanez, Eduardo4 (AUTHOR) eduardoyanez.icos@gmail.com, Senellart, Helene5 (AUTHOR) Helene.Senellart@ico.unicancer.fr, Cassier, Philippe A.6 (AUTHOR) philippe.cassier@lyon.unicancer.fr, Basu, Bristi7 (AUTHOR) bb313@cam.ac.uk, Corr, Bradley R.8 (AUTHOR) bradley.corr@cuanschutz.edu, Girda, Eugenia9 (AUTHOR) eg535@cinj.rutgers.edu, Dutcus, Corina10 (AUTHOR) Corina_Dutcus@Eisai.com, Okpara, Chinyere E.11 (AUTHOR) Chinyere_Okpara@eisai.net, Ghori, Razi12 (AUTHOR) razi.ghori@merck.com, Jin, Fan12 (AUTHOR) fan.jin@merck.com, Groisberg, Roman12 (AUTHOR) roman.groisberg@merck.com, Lwin, Zarnie13 (AUTHOR) Zarnie.Lwin@health.qld.gov.au
المصدر: Gynecologic Oncology. Jul2024, Vol. 186, p182-190. 9p.
مصطلحات موضوعية: *OVARIAN cancer, *CANCER patients, *PEMBROLIZUMAB, *ADVERSE health care events, *OVERALL survival
-
5دورية أكاديمية
المؤلفون: Gaspar, Nathalie1 (AUTHOR) nathalie.gaspar@gustaveroussy.fr, Venkatramani, Rajkumar2 (AUTHOR), Hecker-Nolting, Stefanie3 (AUTHOR), Melcon, Soledad Gallego4 (AUTHOR), Locatelli, Franco5 (AUTHOR), Bautista, Francisco6 (AUTHOR), Longhi, Alessandra7 (AUTHOR), Lervat, Cyril8 (AUTHOR), Entz-Werle, Natacha9 (AUTHOR), Casanova, Michela10 (AUTHOR), Aerts, Isabelle11 (AUTHOR), Strauss, Sandra J12 (AUTHOR), Thebaud, Estelle13 (AUTHOR), Morland, Bruce14 (AUTHOR), Nieto, Adela Cañete15 (AUTHOR), Marec-Berard, Perrine16 (AUTHOR), Gambart, Marion17 (AUTHOR), Rossig, Claudia18 (AUTHOR), Okpara, Chinyere E19 (AUTHOR), He, Cixin20 (AUTHOR)
المصدر: Lancet Oncology. Sep2021, Vol. 22 Issue 9, p1312-1321. 10p.
مصطلحات موضوعية: *DISEASE relapse, *LEUKOCYTE count, *IFOSFAMIDE, *OSTEOSARCOMA, *DRUG dosage, *NEUROECTODERMAL tumors, *THERAPEUTIC use of antineoplastic agents, *QUINOLINE, *ETOPOSIDE, *RESEARCH, *UREA, *CLINICAL trials, *PROTEIN kinase inhibitors, *RESEARCH methodology, *CANCER relapse, *MEDICAL cooperation, *EVALUATION research, *BONE tumors, *TREATMENT effectiveness, *COMPARATIVE studies, *RESEARCH funding, *KARNOFSKY Performance Status, *DRUG side effects, *DRUG resistance in cancer cells, *LONGITUDINAL method
الشركة/الكيان: MERCK & Co. Inc. 001317064 MRK